Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2088086 | Journal of Immunological Methods | 2015 | 11 Pages |
•Comparison of experimental data and in silico class II epitope predictions•Use of binarization and multiple thresholds to analyze HLA class II prediction•In silico methods failed to predict 4/9 epitopes.•In silico methods correctly predicted 2 major epitopes.
The ability to identify immunogenic determinants that activate T-cells is important for the development of new vaccines, allergy therapy and protein therapeutics. In silico MHC-II binding prediction algorithms are often used for T-cell epitope identification. To understand how well those programs predict immunogenicity, we computed HLA binding to peptides spanning the sequence of PE38, a fragment of an anti-cancer immunotoxin, and compared the predicted and experimentally identified T-cell epitopes. We found that the prediction for individual donors did not correlate well with the experimental data. Furthermore, prediction of T-cell epitopes in an HLA heterogenic population revealed that the two strongest epitopes were predicted at multiple cutoffs but the third epitope was predicted negative at all cutoffs and overall 4/9 epitopes were missed at several cutoffs. We conclude that MHC class-II binding predictions are not sufficient to predict the T-cell epitopes in PE38 and should be supplemented by experimental work.